| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 3
| Issue : 1 | Page : 6-8 |
|
|
Liver injury among coronavirus disease patients
Tarika Sharma1, Jitender Singh2
1 Assistant Professor, College of Nursing, Institute of Liver and Biliary Sciences, New Delhi, India
2 Department of Interventional Radiology, ILBS, New Delhi, India
Correspondence Address:
Jitender Singh
Department of Interventional Radiology, ILBS, New Delhi
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jssrp.jssrp_21_21
|
|
|
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as Coronavirus disease 2019 (COVID-19), is a novel coronavirus first identified in December 2019 and has a broad spectrum of clinical presentations. With the expansion of related research, it was found that in addition to respiratory symptoms, digestive involvements and liver injury were reported among COVID-19 patients. Abnormal liver function was observed in cases of COVID-19, manifesting mainly as isolated elevated serum transaminase and lactate dehydrogenase levels. The current review highlights the possible explanation for liver injury among COVID-19 patients.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
